A Viral Genome Landscape of RNA Polyadenylation from KSHV Latent to Lytic Infection

PLoS Pathogens

Volumn 9, Issue 11, 2013, Pages

  Majerciak, Vladimir ^a   Ni, Ting ^b,c   Yang, Wenjing ^b   Meng, Bowen ^a   Zhu, Jun ^b   Zheng, Zhi Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA;

3' RAPID AMPLIFICATION OF CDNA ENDS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LATENT VIRUS INFECTION; NONHUMAN; NORTHERN BLOTTING; NUCLEIC ACID AMPLIFICATION; POLYADENYLATION; POSTTRANSCRIPTIONAL GENE SILENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS GENOME;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; POLYADENYLATION; RNA 3' POLYADENYLATION SIGNALS; RNA, VIRAL; VIRUS LATENCY;

EID: 84888242520     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003749     Document Type: Article

References (67)

1. Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, et al. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93: 14862-14867.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM, (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186-1191.
4. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, et al. (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95: 1406-1412.
5. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, et al. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95: 10866-10871.
6. Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, et al. (1999) Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73: 2232-2242.
7. Lukac DM, Kirshner JR, Ganem D, (1999) Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73: 9348-9361.
8. Sun R, Lin SF, Gradoville L, Miller G, (1996) Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 93: 11883-11888.
9. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, et al. (2005) Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102: 5570-5575.
10. Xu Y, Ganem D, (2010) Making sense of antisense: seemingly noncoding RNAs antisense to the master regulator of Kaposi's sarcoma-associated herpesvirus lytic replication do not regulate that transcript but serve as mRNAs encoding small peptides. J Virol 84: 5465-5475.
11. Colgan DF, Manley JL, (1997) Mechanism and regulation of mRNA polyadenylation. Genes Dev 11: 2755-2766.
12. Lewis JD, Gunderson SI, Mattaj IW, (1995) The influence of 5′ and 3′ end structures on pre-mRNA metabolism. J Cell Sci Suppl 19: 13-19.
13. Wickens M, Anderson P, Jackson RJ, (1997) Life and death in the cytoplasm: messages from the 3′ end. Curr Opin Genet Dev 7: 220-232.
14. Shi Y, Di G, Taylor D, Sarkeshik A, Rice WJ, et al. (2009) Molecular architecture of the human pre-mRNA 3′ processing complex. Mol Cell 33: 365-376.
15. Salisbury J, Hutchison KW, Graber JH, (2006) A multispecies comparison of the metazoan 3′-processing downstream elements and the CstF-64 RNA recognition motif. BMC Genomics 7: 55.
16. Hu J, Lutz CS, Wilusz J, Tian B, (2005) Bioinformatic identification of candidate cis-regulatory elements involved in human mRNA polyadenylation. RNA 11: 1485-1493.
17. Bagga PS, Ford LP, Chen F, Wilusz J, (1995) The G-rich auxiliary downstream element has distinct sequence and position requirements and mediates efficient 3′ end pre-mRNA processing through a trans-acting factor. Nucleic Acids Res 23: 1625-1631.
18. Chen F, Wilusz J, (1998) Auxiliary downstream elements are required for efficient polyadenylation of mammalian pre-mRNAs. Nucleic Acids Res 26: 2891-2898.
19. Millevoi S, Vagner S, (2010) Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation. Nucleic Acids Res 38: 2757-2774.
20. Tian B, Hu J, Zhang H, Lutz CS, (2005) A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res 33: 201-212.
21. Mangone M, Manoharan AP, Thierry-Mieg D, Thierry-Mieg J, Han T, et al. (2010) The landscape of C. elegans 3′UTRs. Science 329: 432-435.
22. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, et al. (2008) The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320: 1344-1349.
23. Di G, Nishida K, Manley JL, (2011) Mechanisms and consequences of alternative polyadenylation. Mol Cell 43: 853-866.
24. Ni T, Yang Y, Hafez D, Yang W, Kiesewetter K, et al. (2013) Distinct polyadenylation landscapes of diverse human tissues revealed by a modified PA-seq strategy. BMC Genomics 14: 615.
25. Hafez D, Ni T, Mukherjee S, Zhu J, Ohler U, (2013) Genome-wide identification and predictive modeling of tissue-specific alternative polyadenylation. Bioinformatics 29: i108-i116.
26. Boyle AP, Guinney J, Crawford GE, Furey TS, (2008) F-Seq: a feature density estimator for high-throughput sequence tags. Bioinformatics 24: 2537-2538.
27. Zhu FX, Cusano T, Yuan Y, (1999) Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 73: 5556-5567.
28. Tang S, Zheng ZM, (2002) Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5′-splice sites and harbors a K8.1 transcription start site. J Biol Chem 277: 14547-14556.
29. Chandriani S, Xu Y, Ganem D, (2010) The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes. J Virol 84: 7934-7942.
30. Pauws E, van Kampen AH, van de Graaf SA, de Vijlder JJ, Ris-Stalpers C, (2001) Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: implications for SAGE analysis. Nucleic Acids Res 29: 1690-1694.
31. Dresang LR, Teuton JR, Feng H, Jacobs JM, Camp DG, et al. (2011) Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. BMC Genomics 12: 625.
32. Wang Y, Li H, Chan MY, Zhu FX, Lukac DM, et al. (2004) Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J Virol 78: 8615-8629.
33. Wang Y, Tang Q, Maul GG, Yuan Y, (2006) Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J Virol 80: 12171-12186.
34. Taylor JL, Bennett HN, Snyder BA, Moore PS, Chang Y, (2005) Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J Virol 79: 15099-15106.
35. Massimelli MJ, Majerciak V, Kruhlak M, Zheng ZM, (2013) Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA. J Virol 87: 243-256.
36. Aoki Y, Yarchoan R, Braun J, Iwamoto A, Tosato G, (2000) Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 96: 1599-1601.
37. Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, et al. (2011) Kaposi's Sarcoma-Associated Herpesvirus ORF57 Promotes Escape of Viral and Human Interleukin-6 from MicroRNA-Mediated Suppression. J Virol 85: 2620-2630.
38. Wang SS, Chang PJ, Chen LW, Chen LY, Hung CH, et al. (2012) Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus. Virus Res 165: 157-169.
39. Majerciak V, Yamanegi K, Zheng ZM, (2006) Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J Virol 80: 11968-11981.
40. Li H, Komatsu T, Dezube BJ, Kaye KM, (2002) The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol 76: 11880-11888.
41. Sarid R, Wiezorek JS, Moore PS, Chang Y, (1999) Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 73: 1438-1446.
42. Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, et al. (2002) Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 76: 3421-3439.
43. Canham M, Talbot SJ, (2004) A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA. J Gen Virol 85: 1363-1369.
44. Kang JG, Majerciak V, Uldrick TS, Wang X, Kruhlak M, et al. (2011) Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J Pathol 225: 378-389.
45. Lin HR, Ganem D, (2011) Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility. Proc Natl Acad Sci U S A 108: 5148-5153.
46. Bellare P, Ganem D, (2009) Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6: 570-575.
47. Chandriani S, Ganem D, (2010) Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J Virol 84: 5565-5573.
48. Pearce M, Matsumura S, Wilson AC, (2005) Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol 79: 14457-14464.
49. Matsumura S, Fujita Y, Gomez E, Tanese N, Wilson AC, (2005) Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J Virol 79: 8493-8505.
50. Chao LC, Jamil A, Kim SJ, Huang L, Martinson HG, (1999) Assembly of the cleavage and polyadenylation apparatus requires about 10 seconds in vivo and is faster for strong than for weak poly(A) sites. Mol Cell Biol 19: 5588-5600.
51. West S, Proudfoot NJ, (2009) Transcriptional termination enhances protein expression in human cells. Mol Cell 33: 354-364.
52. Carswell S, Alwine JC, (1989) Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol Cell Biol 9: 4248-4258.
53. Mayr C, Bartel DP, (2009) Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
54. Hausser J, Syed AP, Bilen B, Zavolan M, (2013) Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res 23: 604-615.
55. Usdin K, (2008) The biological effects of simple tandem repeats: lessons from the repeat expansion diseases. Genome Res 18: 1011-1019.
56. Wyers F, Rougemaille M, Badis G, Rousselle JC, Dufour ME, et al. (2005) Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase. Cell 121: 725-737.
57. Cannon JS, Ciufo D, Hawkins AL, Griffin CA, Borowitz MJ, et al. (2000) A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol 74: 10187-10193.
58. Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, et al. (2003) Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77: 4205-4220.
59. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
60. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
61. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
62. Schneider TD, Stephens RM, (1990) Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18: 6097-6100.
63. Crooks GE, Hon G, Chandonia JM, Brenner SE, (2004) WebLogo: a sequence logo generator. Genome Res 14: 1188-1190.
64. Majerciak V, Yamanegi K, Nie SH, Zheng ZM, (2006) Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J Biol Chem 281: 28365-28378.
65. Pilkington GR, Majerciak V, Bear J, Uranishi H, Zheng ZM, et al. (2012) Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor. J Virol 86: 13089-13094.
66. Massimelli MJ, Kang JG, Majerciak V, Le SY, Liewehr DJ, et al. (2011) Stability of a Long Noncoding Viral RNA Depends on a 9-nt Core Element at the RNA 5′ End to Interact with Viral ORF57 and Cellular PABPC1. Int J Biol Sci 7: 1145-1160.
67. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.